Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher ...

Moderna's Spikevax KP.2 targets the KP.2 variant of the virus. The U.S. Food and Drug Administration has also approved the shot, as well as updated vaccines from Pfizer and BioNTech. Moderna (MRNA ...

It can perform a host of tasks beyond just putting words down, including a very handy function for creating mailing labels. In this guide, we're going to show you how to print labels from Word ...

A potential FDA proposal would label Goldfish “medium” in saturated fat and sodium. (The placement and size of any U.S. label has yet to be determined.) The same product would bear stop-sign ...

Moderna said the Spikevax 2024-2025 formula is expected to be available across the U.S. in the days immediately following approval. Pfizer also said shipping will begin immediately. Thursday ...

Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 ...

Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...

A significant part of their success can be attributed to their growing emphasis on private label brands, the adoption of generative AI in e-commerce, and a strong focus on customer loyalty.